Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 28.78
(0.14%)
CNY 28.78
(0.14%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 483.84 Million CNY | 27.04% |
| 2022 | 380.84 Million CNY | -4.27% |
| 2021 | 397.81 Million CNY | 19.43% |
| 2020 | 333.09 Million CNY | -9.92% |
| 2019 | 369.75 Million CNY | 13.09% |
| 2018 | 326.96 Million CNY | 20.37% |
| 2017 | 271.62 Million CNY | 62.7% |
| 2016 | 166.95 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 114.67 Million CNY | 7.2% |
| 2024 Q1 | 140.59 Million CNY | 71.39% |
| 2024 Q2 | 106.97 Million CNY | -23.91% |
| 2023 Q2 | 131.24 Million CNY | -20.53% |
| 2023 FY | 483.84 Million CNY | 27.04% |
| 2023 Q4 | 82.03 Million CNY | -22.18% |
| 2023 Q1 | 165.15 Million CNY | 519.06% |
| 2023 Q3 | 105.41 Million CNY | -19.68% |
| 2022 Q1 | 100.36 Million CNY | -8.07% |
| 2022 Q4 | 26.67 Million CNY | -78.8% |
| 2022 Q2 | 127.97 Million CNY | 27.5% |
| 2022 FY | 380.84 Million CNY | -4.27% |
| 2022 Q3 | 125.82 Million CNY | -1.68% |
| 2021 FY | 397.81 Million CNY | 19.43% |
| 2021 Q4 | 109.18 Million CNY | 7.15% |
| 2021 Q3 | 101.89 Million CNY | -3.11% |
| 2021 Q1 | 81.57 Million CNY | -28.67% |
| 2021 Q2 | 105.16 Million CNY | 28.92% |
| 2020 FY | 333.09 Million CNY | -9.92% |
| 2020 Q3 | 88.81 Million CNY | 41.29% |
| 2020 Q2 | 62.85 Million CNY | -6.26% |
| 2020 Q1 | 67.05 Million CNY | -49.39% |
| 2020 Q4 | 114.36 Million CNY | 28.76% |
| 2019 FY | 369.75 Million CNY | 13.09% |
| 2019 Q4 | 132.5 Million CNY | 71.38% |
| 2019 Q3 | 77.31 Million CNY | -29.02% |
| 2019 Q2 | 108.92 Million CNY | 113.51% |
| 2019 Q1 | 51.01 Million CNY | -56.24% |
| 2018 FY | 326.96 Million CNY | 20.37% |
| 2018 Q4 | 116.58 Million CNY | 0.0% |
| 2017 FY | 271.62 Million CNY | 62.7% |
| 2016 FY | 166.95 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | 1.14 Billion CNY | 57.77% |